Homology Medicines Inc
FIXX
Market Cap$3.02M
Close$
$-0.34
136.7% downside
Current Fair Value
136.7% downsideOvervalued by 136.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.02 Million |
|---|---|
| Enterprise Value | $-40,289,255.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.12 |
| Beta | -0.11 |
| Outstanding Shares | 12,197,615 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.4 |
|---|---|
| PEG | 0.04 |
| Price to Sales | -0.93 |
| Price to Book Ratio | -0.47 |
| Enterprise Value to Revenue | 28.41 |
| Enterprise Value to EBIT | 0.7 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.29 |
| Debt to Equity | -0.94 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Homology Medicines Inc
CEO: Arthur Tzianabos